Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Regulated necrosis in kidney ischemia-reperfusion injury.

Pefanis A, Ierino FL, Murphy JM, Cowan PJ.

Kidney Int. 2019 Aug;96(2):291-301. doi: 10.1016/j.kint.2019.02.009. Epub 2019 Mar 7. Review.

PMID:
31005270
2.

A Fad Diet Causing Acute Kidney Injury.

Wallace H, Williams DS, Pefanis A.

Nephrology (Carlton). 2018 Oct;23(10):962-963. doi: 10.1111/nep.13237. No abstract available.

PMID:
30251315
3.

Point-prevalence survey of healthcare facility-onset healthcare-associated Clostridium difficile infection in Greek hospitals outside the intensive care unit: The C. DEFINE study.

Skoutelis A, Pefanis A, Tsiodras S, Sipsas NV, Lelekis M, Lazanas MC, Gargalianos P, Dalekos GN, Roilides E, Samonis G, Maltezos E, Hatzigeorgiou D, Lada M, Metallidis S, Stoupis A, Chrysos G, Karnesis L, Symbardi S, Loupa CV, Giamarellou H, Kioumis I, Sambatakou H, Tsianos E, Kotsopoulou M, Georgopali A, Liakou K, Perlorentzou S, Levidiotou S, Giotsa-Toutouza M, Tsorlini-Christoforidou H, Karaiskos I, Kouppari G, Trikka-Graphakos E, Ntrivala MA, Themeli-Digalaki K, Pangalis A, Kachrimanidou M, Martsoukou M, Karapsias S, Panopoulou M, Maraki S, Orfanou A, Petinaki E, Orfanidou M, Baka V, Stylianakis A, Spiliopoulou I, Smilakou S, Zerva L, Vogiatzakis E, Belesiotou E, Gogos CA.

PLoS One. 2017 Aug 16;12(8):e0182799. doi: 10.1371/journal.pone.0182799. eCollection 2017.

4.

Patterns of use and appropriateness of antibiotics prescribed to patients receiving haemodialysis: an observational study.

Hui K, Nalder M, Buising K, Pefanis A, Ooi KY, Pedagogos E, Nelson C, Kirkpatrick CMJ, Kong DCM.

BMC Nephrol. 2017 May 12;18(1):156. doi: 10.1186/s12882-017-0575-9.

5.

eMAP:CKD: electronic diagnosis and management assistance to primary care in chronic kidney disease.

Pefanis A, Botlero R, Langham RG, Nelson CL.

Nephrol Dial Transplant. 2018 Jan 1;33(1):121-128. doi: 10.1093/ndt/gfw366.

6.

Pilot study of the completeness of notification of adult tuberculosis in Athens, Greece.

Ibarz-Pavón AB, Papaventsis D, Kalkouni R, Metaxas G, Spala G, Georgakopoulou T, Gerakis T, Pefanis A, Vogiatzakis E.

Int J Tuberc Lung Dis. 2016 Jul;20(7):920-5. doi: 10.5588/ijtld.15.0907.

PMID:
27287645
7.

A case of paravalvular abscess due to Pseudomonas aeruginosa assessed by 18Fluoro-2-deoxyglucose positron emission tomography/computed tomography.

Pianou NK, Georgakopoulos A, Apeithi E, Kloudas S, Zagklavira P, Pefanis A, Anagnostopoulos CD.

Int J Cardiol. 2016 Jul 15;215:463-5. doi: 10.1016/j.ijcard.2016.04.119. Epub 2016 Apr 28. No abstract available.

PMID:
27131765
8.

Management and investigation of viral gastroenteritis nosocomial outbreaks: lessons learned from a recent outbreak, Greece, 2012.

Sideroglou T, Kontopidou F, Mellou K, Maragos A, Potamiti-Komi M, Gerakis T, Vogiatzakis E, Pefanis A, Georgakopoulou T, Maltezou H.

Hippokratia. 2014 Jul-Sep;18(3):204-8.

9.

Action Plan to combat infections due to carbapenem-resistant, Gram-negative pathogens in acute-care hospitals in Greece.

Maltezou HC, Kontopidou F, Dedoukou X, Katerelos P, Gourgoulis GM, Tsonou P, Maragos A, Gargalianos P, Gikas A, Gogos C, Koumis I, Lelekis M, Maltezos E, Margariti G, Nikolaidis P, Pefanis A, Petrikkos G, Syrogiannopoulos G, Tsakris A, Vatopoulos A, Saroglou G, Kremastinou J, Daikos GL; Working Group for the National Action Plan to Combat Infections due to Carbapenem-Resistant, Gram-Negative Pathogens in Acute-Care Hospitals in Greece.

J Glob Antimicrob Resist. 2014 Mar;2(1):11-16. doi: 10.1016/j.jgar.2013.06.002. Epub 2013 Aug 13.

PMID:
27873631
10.

Efficacy of tigecycline alone and in combination with gentamicin in the treatment of experimental endocarditis due to linezolid-resistant Enterococcus faecium.

Pontikis K, Pefanis A, Tsaganos T, Tzepi IM, Carrer DP, Giamarellou H.

Antimicrob Agents Chemother. 2013 Jul;57(7):3392-4. doi: 10.1128/AAC.00646-13. Epub 2013 Apr 15.

11.

Guidelines adherence for patients with community acquired pneumonia in a Greek hospital.

Triantafyllidis C, Kapordelis V, Papaetis GS, Orphanidou D, Apostolidou M, Nikolopoulos I, Pefanis A.

Eur Rev Med Pharmacol Sci. 2012 Jan;16(1):1-9.

PMID:
22338542
12.

The challenges of antimicrobial drug resistance in Greece.

Miyakis S, Pefanis A, Tsakris A.

Clin Infect Dis. 2011 Jul 15;53(2):177-84. doi: 10.1093/cid/cir323. Review.

PMID:
21690626
13.

Efficacy of carbapenems against a metallo-β-lactamase-producing Escherichia coli clinical isolate in a rabbit intra-abdominal abscess model.

Souli M, Konstantinidou E, Tzepi I, Tsaganos T, Pefanis A, Chryssouli Z, Galani I, Giamarellos-Bourboulis E, Giamarellou H.

J Antimicrob Chemother. 2011 Mar;66(3):611-7. doi: 10.1093/jac/dkq470. Epub 2010 Dec 21.

PMID:
21177674
14.

Fever of unknown origin: discrimination between infectious and non-infectious causes.

Efstathiou SP, Pefanis AV, Tsiakou AG, Skeva II, Tsioulos DI, Achimastos AD, Mountokalakis TD.

Eur J Intern Med. 2010 Apr;21(2):137-43. doi: 10.1016/j.ejim.2009.11.006. Epub 2009 Dec 6.

PMID:
20206887
15.

A patient with recurrent episodes of abdominal pain and hypovolemic shock.

Solomon S, Pefanis A, Papaetis GS, Ginos C, Kythreotis P, Achimastos A.

Am J Emerg Med. 2009 Jul;27(6):755.e5-7. doi: 10.1016/j.ajem.2008.10.010. No abstract available.

PMID:
19751646
16.

Successful treatment with moxifloxacin of experimental aortic valve endocarditis due to methicillin-resistant Staphylococcus aureus (MRSA).

Galani L, Pefanis A, Sakka V, Iliopoulos D, Donta I, Triantafyllidi H, Skiadas I, Karayiannakos P, Giamarellou H.

Int J Antimicrob Agents. 2009 Jan;33(1):65-9. doi: 10.1016/j.ijantimicag.2008.07.021. Epub 2008 Sep 24.

PMID:
18818055
17.

Asymptomatic stage I sarcoidosis complicated by pulmonary tuberculosis: a case report.

Papaetis GS, Pefanis A, Solomon S, Tsangarakis I, Orphanidou D, Achimastos A.

J Med Case Rep. 2008 Jul 7;2:226. doi: 10.1186/1752-1947-2-226.

18.

Efficacy of teicoplanin, administered in two different regimens, in the treatment of experimental endocarditis due to Enterococcus faecalis.

Pavleas J, Skiada A, Daikos GL, Pefanis A, Giamarellos-Bourboulis E, Kanellakopoulou K, Tsaganos T, Perrea D, Donta I, Karayannakos P, Giamarellou H.

J Chemother. 2008 Apr;20(2):208-12.

PMID:
18467247
19.

Saccharomyces boulardii fungaemia in an intensive care unit patient treated with caspofungin.

Lolis N, Veldekis D, Moraitou H, Kanavaki S, Velegraki A, Triandafyllidis C, Tasioudis C, Pefanis A, Pneumatikos I.

Crit Care. 2008;12(2):414. doi: 10.1186/cc6843. Epub 2008 Apr 9.

20.

Interactions of Ceftazidime and Amikacin on Multiresistant Pseudomonas aeruginosa: Have They Altered in the Six-Year Period from 1988 to 1994?

Giamarellos-Bourboulis EJ, Pefanis A, Grecka P, Kanellakopoulou K, Giamarellou H.

Clin Drug Investig. 1998;16(2):167-71.

PMID:
18370535
21.

Dexamethasone as adjuvant therapy to moxifloxacin attenuates valve destruction in experimental aortic valve endocarditis due to Staphylococcus aureus.

Skiadas I, Pefanis A, Papalois A, Kyroudi A, Triantafyllidi H, Tsaganos T, Giamarellou H.

Antimicrob Agents Chemother. 2007 Aug;51(8):2848-54. Epub 2007 Jun 11.

22.

Candiduria in critically ill patients: an early candidemia marker when coupled with multiple blood specimens PCR assays?

Dimopoulos G, Velegraki A, Pefanis A, Karabinis A.

Hepatogastroenterology. 2007 Mar;54(74):354-8.

PMID:
17523273
23.

Prognostic significance of plasma resistin levels in patients with atherothrombotic ischemic stroke.

Efstathiou SP, Tsiakou AG, Tsioulos DI, Panagiotou TN, Pefanis AV, Achimastos AD, Mountokalakis TD.

Clin Chim Acta. 2007 Mar;378(1-2):78-85. Epub 2006 Nov 7.

PMID:
17173885
24.

Lung mass caused by Phoma exigua.

Balis E, Velegraki A, Fragou A, Pefanis A, Kalabokas T, Mountokalakis T.

Scand J Infect Dis. 2006;38(6-7):552-5.

PMID:
16798712
25.

Thymoma with immunodeficiency (Good's syndrome): review of the literature apropos three cases.

Miyakis S, Pefanis A, Passam FH, Christodulakis GR, Roussou PA, Mountokalakis TD.

Scand J Infect Dis. 2006;38(4):314-9.

PMID:
16718939
26.

Linezolid in prophylaxis against experimental aortic valve endocarditis due to Streptococcus oralis or Enterococcus faecalis.

Athanassopoulos G, Pefanis A, Sakka V, Iliopoulos D, Perrea D, Giamarellou H.

Antimicrob Agents Chemother. 2006 Feb;50(2):654-7.

27.

Antimicrobial resistance of Streptococcus pneumoniae isolates in Athens, Greece.

Kanavaki S, Mantadakis E, Karabela S, Anatoliotaki M, Makarona M, Moraitou H, Pefanis A, Samonis G.

Eur J Clin Microbiol Infect Dis. 2005 Oct;24(10):693-6.

PMID:
16261303
28.

Successful moxifloxacin prophylaxis against experimental streptococcal aortic valve endocarditis.

Sakka V, Galani L, Pefanis A, Iliopoulos D, Athanasopoulos G, Donta I, Giamarellou H.

J Antimicrob Chemother. 2005 Dec;56(6):1160-2. Epub 2005 Oct 4.

PMID:
16204339
29.

Plasma adiponectin levels and five-year survival after first-ever ischemic stroke.

Efstathiou SP, Tsioulos DI, Tsiakou AG, Gratsias YE, Pefanis AV, Mountokalakis TD.

Stroke. 2005 Sep;36(9):1915-9. Epub 2005 Aug 18.

PMID:
16109902
30.

Serial serum procalcitonin changes in the prognosis of acute stroke.

Miyakis S, Georgakopoulos P, Kiagia M, Papadopoulou O, Pefanis A, Gonis A, Mountokalakis TD.

Clin Chim Acta. 2004 Dec;350(1-2):237-9. No abstract available.

PMID:
15530484
31.

Acute pyelonephritis in adults: prediction of mortality and failure of treatment.

Efstathiou SP, Pefanis AV, Tsioulos DI, Zacharos ID, Tsiakou AG, Mitromaras AG, Mastorantonakis SE, Kanavaki SN, Mountokalakis TD.

Arch Intern Med. 2003 May 26;163(10):1206-12.

PMID:
12767958
32.

A new classification tool for clinical differentiation between haemorrhagic and ischaemic stroke.

Efstathiou SP, Tsioulos DI, Zacharos ID, Tsiakou AG, Mitromaras AG, Mastorantonakis SE, Pefanis AV, Mountokalakis TD.

J Intern Med. 2002 Aug;252(2):121-9.

33.

Brachyspira (Serpulina) pilosicoli spirochetemia in an immunocompromised patient.

Kanavaki S, Mantadakis E, Thomakos N, Pefanis A, Matsiota-Bernard P, Karabela S, Samonis G.

Infection. 2002 Jun;30(3):175-7.

PMID:
12120947
34.

Evidence of less severe aortic valve destruction after treatment of experimental staphylococcal endocarditis with vancomycin and dexamethasone.

Siaperas P, Pefanis A, Iliopoulos D, Katsarolis I, Kyroudi-Voulgari A, Donta I, Karayiannakos P, Giamarellou H.

Antimicrob Agents Chemother. 2001 Dec;45(12):3531-7.

35.

Case report. Chronic necrotizing pulmonary aspergillosis in a non-neutropenic patient treated with liposomal amphotericin B.

Filippou N, Papachristou K, Ilias I, Pefanis A, Papaleftheris E, Iliopoulos I.

Mycoses. 2000 Sep;43(7-8):313-5.

PMID:
11036403
36.

Successful trovafloxacin prophylaxis against experimental streptococcal aortic valve endocarditis.

Katsarolis I, Pefanis A, Iliopoulos D, Siaperas P, Karayiannakos P, Giamarellou H.

Antimicrob Agents Chemother. 2000 Sep;44(9):2564-6.

37.

Single-oral-dose azithromycin prophylaxis against experimental streptococcal or staphylococcal aortic valve endocarditis.

Tsitsika A, Pefanis A, Perdikaris GS, Donta I, Karayiannakos P, Giamarellou H.

Antimicrob Agents Chemother. 2000 Jun;44(6):1754-6.

38.

Visceral leishmaniasis in renal transplant recipients: successful treatment with liposomal amphotericin B (AmBisome).

Boletis JN, Pefanis A, Stathakis C, Helioti H, Kostakis A, Giamarellou H.

Clin Infect Dis. 1999 Jun;28(6):1308-9.

PMID:
10451172
39.

Successful single-dose teicoplanin prophylaxis against experimental streptococcal, enterococcal, and staphylococcal aortic valve endocarditis.

Perdikaris GS, Pefanis A, Giamarellou H, Nikolopoulos A, Margaris EP, Donta I, Tsitsika A, Karayiannakos P.

Antimicrob Agents Chemother. 1997 Sep;41(9):1916-21.

40.

Ciprofloxacin and imipenem alone or in combination in experimental aortic valve endocarditis due to a ciprofloxacin borderline susceptible strain of Pseudomonas aeruginosa.

Giamarellou H, Tsapogas P, Pefanis A, Donta I, Perdikaris G, Karayiannakos P.

Int J Antimicrob Agents. 1996 May;7(1):23-8.

PMID:
18611731
41.

Vancomycin or vancomycin plus netilmicin for methicillin- and gentamicin-resistant Staphylococcus aureus aortic valve experimental endocarditis.

Perdikaris G, Giamarellou H, Pefanis A, Donta I, Karayiannakos P.

Antimicrob Agents Chemother. 1995 Oct;39(10):2289-94.

42.
43.

Evaluation of the efficacy and safety of isepamicin in the treatment of various bacterial infections.

Petrikkos G, Giamarellou H, Tsagaraki C, Pefanis A.

J Chemother. 1995 Jun;7 Suppl 2:161-4.

PMID:
8622106
44.

Activity of fleroxacin alone and in combination with clindamycin or metronidazole in experimental intra-abdominal abscesses.

Pefanis A, Thauvin-Eliopoulos C, Holden J, Eliopoulos GM, Ferraro MJ, Moellering RC Jr.

Antimicrob Agents Chemother. 1994 Feb;38(2):252-5.

45.

Efficacy of ceftriaxone plus tazobactam in a rat model of intraabdominal abscess due to Bacteroides fragilis.

Pefanis A, Thauvin-Eliopoulos C, Eliopoulos GM, Moellering RC.

J Antimicrob Chemother. 1993 Aug;32(2):307-12.

PMID:
8226433
46.

Activity of ampicillin-sulbactam and oxacillin in experimental endocarditis caused by beta-lactamase-hyperproducing Staphylococcus aureus.

Pefanis A, Thauvin-Eliopoulos C, Eliopoulos GM, Moellering RC Jr.

Antimicrob Agents Chemother. 1993 Mar;37(3):507-11.

47.

Efficacy of ceftazidime and aztreonam alone or in combination with amikacin in experimental left-sided Pseudomonas aeruginosa endocarditis.

Pefanis A, Giamarellou H, Karayiannakos P, Donta I.

Antimicrob Agents Chemother. 1993 Feb;37(2):308-13.

48.

Total and cause-specific mortality in a population based cohort of diabetics in Greece.

Katsilambros N, Hatzakis A, Perdicaris G, Pefanis A, Touloumi G.

Diabete Metab. 1991 Jul-Aug;17(4):410-4.

PMID:
1915999
49.

Peripheral occlusive arterial disease in longstanding diabetes mellitus. A population study.

Katsilambros N, Hatzakis A, Perdikaris G, Pefanis A, Papazachos G, Papadoyannis D, Balas P.

Int Angiol. 1989 Jan-Mar;8(1):36-40.

PMID:
2768957

Supplemental Content

Loading ...
Support Center